The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghalib, H. W.
Right arrow Articles by Reed, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghalib, H. W.
Right arrow Articles by Reed, S. G.

The Journal of Immunology, Vol 154, Issue 9 4623-4629, Copyright © 1995 by American Association of Immunologists


ARTICLES

IL-12 enhances Th1-type responses in human Leishmania donovani infections

HW Ghalib, JA Whittle, M Kubin, FA Hashim, AM el-Hassan, KH Grabstein, G Trinchieri and SG Reed
Department of Microbiology, College of Medicine, University of Juba, Khartoum, Sudan.

IL-12 is a pluripotent cytokine that interacts with NK and T cells to play a central role in the initiation and maintenance of Th1 responses and IFN-gamma production. Because of the interactive relationship between IL-12 and IFN-gamma response to infectious organisms, a study was undertaken to examine the role of IL-12 in the immune regulation of human visceral leishmaniasis (VL). Human (Hu) VL is associated with immune dysfunction and the appearance of IL-10 mRNA, not present in healed individuals. We found that PBMC from treated VL patients produced both IL-12 p40 and IFN-gamma in response to in vitro stimulation with Leishmania donovani. The production of both IL-12 p40 and IFN-gamma were interdependent and were abrogated by the addition of exogenous Hu rIL-10. In contrast, PBMC from active VL patients did not produce IL-12 p40 or IFN-gamma in response to L. donovani lysate. Neutralizing anti-IL-10 mAb led to the enhancement of IFN-gamma production by active VL PBMC cultured with L. donovani lysate, and this enhanced IFN-gamma production was blocked by anti-IL-12 mAb. The addition of exogenous Hu rIL-12 to PBMC from active VL patients resulted in the augmentation of IFN-gamma in response to L. donovani lysate. Therefore, treatment of active VL patient PBMC with anti-IL-10 or IL-12 shifted the response toward a Th1-type response with the production of IFN-gamma. These results indicate that IL-12 may play an important role in the regulation of the cellular immune responses in Hu VL.


This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Salhi, V. Rodrigues Jr., F. Santoro, H. Dessein, A. Romano, L. R. Castellano, M. Sertorio, S. Rafati, C. Chevillard, A. Prata, et al.
Immunological and Genetic Evidence for a Crucial Role of IL-10 in Cutaneous Lesions in Humans Infected with Leishmania braziliensis
J. Immunol., May 1, 2008; 180(9): 6139 - 6148.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Saha, S. Mondal, R. Ravindran, S. Bhowmick, D. Modak, S. Mallick, M. Rahman, S. Kar, R. Goswami, S. K. Guha, et al.
IL-10- and TGF-beta-Mediated Susceptibility in Kala-azar and Post-kala-azar Dermal Leishmaniasis: The Significance of Amphotericin B in the Control of Leishmania donovani Infection in India
J. Immunol., October 15, 2007; 179(8): 5592 - 5603.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Nylen, R. Maurya, L. Eidsmo, K. D. Manandhar, S. Sundar, and D. Sacks
Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis
J. Exp. Med., April 16, 2007; 204(4): 805 - 817.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. F. Hassan, Y. Zhang, C. R. Engwerda, P. M. Kaye, H. Sharp, and Q. D. Bickle
The Schistosoma mansoni Hepatic Egg Granuloma Provides a Favorable Microenvironment for Sustained Growth of Leishmania donovani
Am. J. Pathol., September 1, 2006; 169(3): 943 - 953.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Sassi, B. Largueche-Darwaz, A. Collette, A. Six, D. Laouini, P. A. Cazenave, and K. Dellagi
Mechanisms of the Natural Reactivity of Lymphocytes from Noninfected Individuals to Membrane-Associated Leishmania infantum Antigens
J. Immunol., March 15, 2005; 174(6): 3598 - 3607.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H. W. Murray
Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis
Antimicrob. Agents Chemother., August 1, 2001; 45(8): 2185 - 2197.
[Full Text] [PDF]


Home page
J. Immunol.Home page
A. Pohl-Koppe, K. E. Balashov, A. C. Steere, E. L. Logigian, and D. A. Hafler
Identification of a T Cell Subset Capable of both IFN-{gamma} and IL-10 Secretion in Patients with Chronic Borrelia burgdorferi Infection
J. Immunol., February 15, 1998; 160(4): 1804 - 1810.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Wang, C. A. Ellison, J. G. Gartner, and K. T. HayGlass
Natural Killer Cell Depletion Fails to Influence Initial CD4 T Cell Commitment In Vivo in Exogenous Antigen-Stimulated Cytokine and Antibody Responses
J. Immunol., February 1, 1998; 160(3): 1098 - 1105.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. W. Murray, J. Hariprashad, and R. L. Coffman
Behavior of  Visceral Leishmania donovani in an Experimentally Induced T Helper Cell 2 (Th2)-Associated Response Model
J. Exp. Med., March 3, 1997; 185(5): 867 - 874.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.